Clinical utility of circulating tumor DNA detection for diagnosis of breast cancer / 中国癌症杂志
China Oncology
;
(12): 947-951, 2016.
Article
in Chinese
| WPRIM
| ID: wpr-508373
ABSTRACT
With the development of the next generation sequencing technology, considerable attention has been paid to the utility of circulating tumor DNA (ctDNA) detection in breast cancer. There are many clinical trials showed the ctDNA detection is a potential biomarker for the diagnosis, management and prognosis of breast cancer. ctDNA detection can provide a more accurate diagnosis for patients to guide clinical treatment in precision medicine era.
Full text:
Available
Index:
WPRIM (Western Pacific)
Type of study:
Diagnostic study
Language:
Chinese
Journal:
China Oncology
Year:
2016
Type:
Article
Similar
MEDLINE
...
LILACS
LIS